Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials

SUMMARY: In this meta-analysis of all Merck-conducted, placebo-controlled clinical trials of alendronate, the occurrence of AF was uncommon, with most studies reporting two or fewer events. Across all studies, no clear association between overall bisphosphonate exposure and the rate of serious or no...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrett-Connor, E., Swern, A. S., Hustad, C. M., Bone, H. G., Liberman, U. A., Papapoulos, S., Wang, H., de Papp, A., Santora, A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249176/
https://www.ncbi.nlm.nih.gov/pubmed/21369791
http://dx.doi.org/10.1007/s00198-011-1546-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249176/
https://www.ncbi.nlm.nih.gov/pubmed/21369791
http://dx.doi.org/10.1007/s00198-011-1546-9

Ejemplares similares